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Abstract 1 
At the heart of an innate immune response lies a tightly regulated gene expression program.  This 2 
precise regulation is crucial because small changes can shift the balance from protective to 3 
destructive immunity.  Here we identify a frequently used alternative splice site in the gene 4 
oligoadenylate synthetase 1g (Oas1g), a key component of the 2-5A antiviral system.  Usage of this 5 
splice site leads to the generation of a transcript subject to decay, and removal of the site leads to 6 
increased expression of Oas1g and an improved antiviral response.  However, removal of the splice 7 
site also leads to an increase in apoptotic cell death, suggesting this splicing event exists as a 8 
compromise between the pathogen protective benefits and collateral damage associated with OAS1g 9 
activity.  Across the innate immune response, we show a multitude of alternative splicing events 10 
predicted to lead to decay exist and thus, have the potential to play a significant role in the regulation 11 
of gene expression in innate immunity. 12 
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Introduction 24 
Central to an inflammatory response is a robust and coordinated gene expression program.  Precise 25 
regulation of this gene expression program is crucial to avoid immune-mediated collateral damage 26 
(Kontoyiannis et al. 1999).  Though transcription and protein turnover are the best-examined areas 27 
of gene expression regulation (Gautier et al. 2012; Chen and Chen 2013; Smale and Natoli 2014; 28 
Smale et al. 2014), a variety of post-transcriptional mechanisms have emerged that play a role in the 29 
fine-tuning of an inflammatory response.  Well-studied examples include mRNA stabilization (Hao 30 
and Baltimore 2009), mRNA deadenylation (Leppek et al. 2013), and microRNA regulation 31 
(O’Connell et al. 2012).   32 
The wealth of transcriptomic data generated over the last decade has shed light on the 33 
widespread nature of alternative mRNA splicing of mammalian genes.  While most mammalian 34 
genes exhibit alternative splicing (AS) (Wang et al. 2008; Pan et al. 2008), not all of the produced 35 
transcripts encode functional proteins. Though AS can act to increase proteomic diversity, it can also 36 
generate unproductive isoforms subject to either cytoplasmic or nuclear decay (Bitton et al. 2015; 37 
Lareau et al. 2007a).  In cases where a splicing event leads to the introduction of a premature 38 
termination codon (PTC), degradation is believed to occur via the nonsense-mediated mRNA decay 39 
(NMD) machinery in the cytoplasm through a process called alternative splicing-coupled NMD (AS-40 
NMD) (Lareau et al. 2007a; Kervestin and Jacobson 2012; Jangi and Sharp 2014).  Coupling of AS 41 
to NMD provides cells with a potential mode of downregulation of expression of a given gene.  It 42 
has been estimated that 10-30% of mammalian genes may be regulated post-transcriptionally 43 
through AS-NMD (Lewis et al. 2003; Mendell et al. 2004; Weischenfeldt et al. 2012; Jangi and 44 
Sharp 2014).  However, beyond splicing factor regulation (Jangi and Sharp 2014; Lareau et al. 45 
2007b), the extent to which AS-NMD represents post-transcriptional gene expression control as 46 
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opposed to noise in the splicing process is a contentious issue, and the role it plays in the finely tuned 47 
innate immune response has yet to be explored (McGlincy and Smith 2008).   48 
Here we identify a frequently used unproductive splicing event in oligoadenylate synthetase 49 
1g (Oas1g), an important murine anti-viral response factor.  Upon binding viral dsRNA, OAS1g acts 50 
to convert ATP into 2’-5’ linked oligoadenylates (2-5A), which in turn activate RNase L.  Activated 51 
RNase L degrades viral RNA, in turn inhibiting viral replication and propagation (Silverman 2007).  52 
Although humans have a single Oas1 gene, in mice the Oas1 gene locus underwent a series of 53 
duplication events leading to the existence of eight Oas1 paralogues.  Of the paralogues, only OAS1a 54 
and OAS1g have been shown to be enzymatically active, with OAS1g producing significantly more 55 
oligoadenylates as compared to OAS1a (Kakuta et al. 2002; Elkhateeb et al. 2016).  We show that 56 
removal of the Oas1g alternative splice site in a murine macrophage cell line leads to increased 57 
expression of Oas1g, both in stimulated and unstimulated conditions.  Further, this increased 58 
expression of Oas1g improves the ability of macrophages that lack the unproductive splice site to 59 
withstand infection by encephalomyocarditis virus (EMCV).  However, removal of the Oas1g 60 
alternative splice site also leads to an increase in apoptotic cell death in uninfected cells, a finding 61 
consistent with the idea that activation of the 2-5A anti-viral system can be detrimental to host fitness 62 
(Zhou et al. 1997; Andersen et al. 2007; Carey et al. 2019).  Beyond Oas1g, we find AS-NMD events 63 
in a number of other crucial innate immune response transcripts, suggesting this is a common 64 
mechanism of mitigation for responses that might otherwise be unchecked or inappropriately scaled.   65 
 66 
 67 
 68 
 69 
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Results 70 
Oas1g has a Frequent AS-NMD Event  71 
AS events have the potential to generate both productive isoforms coding for functional proteins, as 72 
well as unproductive isoforms subject to degradation (Figure 1A).  The latter allows for the use of 73 
AS as a post-transcriptional mechanism of gene-expression regulation.  To investigate the extent to 74 
which unproductive splicing acts as a post-transcriptional regulator of gene expression during 75 
inflammation, we analyzed nuclear fractionation RNA-sequencing data from mouse bone marrow-76 
derived macrophages (BMDMs) stimulated with the TLR3 agonist poly(I:C) for up to 12 hrs 77 
(Frankiw et al. 2019).  Activation of TLR3 leads to activation of interferon regulator factors, 78 
production of interferon-α and β (IFN-α/β), and induction of a type I interferon response (Perales-79 
Linares and Navas-Martin 2013).  From this data, we identified frequent usage of an alternative 5’ 80 
splice site at the third splice junction in the Oas1g gene (Figure 1B).  At each time-point we analyzed, 81 
this alternative “unproductive” splice site was frequently selected over the consensus “productive” 82 
splice site (Figure 1C, left).  This is evident by comparing the number of reads that map across the 83 
two different junctions, as well as through the use of the computational program MISO, which 84 
utilizes a probabilistic framework to estimate the expression of alternatively spliced isoforms (Katz 85 
et al. 2010) (Figure 1C, right).  The expression metric is represented by the value Percent Spliced In 86 
(PSI; Ψ), which is an estimate of the fraction of transcripts that utilize the alternative splice site.  The 87 
unproductive splice isoform of Oas1g represents an ideal NMD substrate as it contains a termination 88 
codon located >50 nucleotides upstream of a downstream exon–exon junction.  As might be 89 
expected, depletion of the NMD factor Upf1 leads to increased expression levels of Oas1g (Figure 90 
S1A, S1B).  Of interest was the strength of the productive and unproductive splice site, which can 91 
be quantified using a maximum entropy model (Yeo and Burge 2004).  We find the productive and 92 
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unproductive 5’ splice sites are similar in strength, and are fairly strong with respect to all expressed 93 
junctions (Figure S1C). 94 
Next we looked at this AS event in the context of all expressed junctions. To do this, we 95 
calculated the alternative junction usage at each expressed junction from the BMDM data-set 96 
stimulated with poly(I:C) for 8 hours (Figure 1D, data from other induced time-points shown in 97 
Figure S1D, S1E).  From this junction-centric viewpoint, the sequencing data supports the 98 
conclusion that most expressed junctions splice with high fidelity (Figure 1E).  Still, there is some 99 
alternative junction usage, which can be attributed to both regulated AS events as well as splicing 100 
noise.  With respect to the alternatively spliced junction of Oas1g, it ranks among the top percentile 101 
of alternative junction usage, supporting the conclusion that this AS event is among the most 102 
frequently utilized in poly(I:C) stimulated BMDMs (Figure 1E).   103 
 104 
Removal of Alternative Splice Site Alters Oas1g Expression and Host Response to EMCV 105 
In order to explore the effect of this AS event on Oas1g expression, and correspondingly the antiviral 106 
response, we used clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-107 
associated protein-9 nuclease (Cas9) technology to engineer murine RAW 264.7 cell lines devoid of 108 
this unproductive splice site (Figure 2A).  In parallel, cell lines expressing Cas9 and a non-targeting 109 
guide were generated.  We selected seven clones that had the splice site removed in both alleles, 110 
which we designate as “fixed” clones (Figure 2B, S2).  RT-PCR upon stimulation with poly(I:C) 111 
both confirmed alternative splice site usage in control populations, and showed forced productive 112 
splicing in these fixed clones (Figure 2C). 113 
To determine what effect this forced productive splicing has on Oas1g expression, we 114 
monitored mRNA levels of Oas1g in both unstimulated and stimulated (8 hrs poly(I:C)) conditions.  115 
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In each case, the engineered lines lacking the unproductive Oas1g splice site had significantly higher 116 
levels of expression, presumably due to lack of NMD associated with selection of the unproductive 117 
splice site (Figure 2D).  Of interest, levels of Oas1g in unstimulated Oas1g splice site engineered 118 
cells were similar to levels of Oas1g in stimulated control cells.  Next, to determine the effect of 119 
removal of the unproductive splice site with respect to the anti-viral response, we used EMCV to 120 
infect both groups of macrophages.  EMCV is a (+)ssRNA member of the Picornaviridae family 121 
that replicate through partially dsRNA intermediates (Carocci and Bakkali-Kassimi 2012).  Infection 122 
has been shown to cause accumulation of 2-5A, and viral replication is sensitive to the OAS/RNase 123 
L pathway (Hearl and Johnston 1987; Zhou et al. 1997).  As oligoadenylate synthetases bind viral 124 
dsRNA, the RNA activators in EMCV-infected cells are believed to be the viral replicative 125 
intermediates (Silverman 2007).  Upon 18 hrs of infection with EMCV, we again observed 126 
significantly higher levels of Oas1g expression in the engineered lines lacking the unproductive 127 
Oas1g splice site (Figure 2E).  Using qPCR to measure levels of EMCV following 18 hrs. of 128 
infection, we found that the engineered lines controlled viral replication more efficiently than the 129 
control lines (Figure 2F).  Thus, we conclude that forced productive splicing of Oas1g improves the 130 
antiviral defense through increased expression of Oas1g.  Finally, since activation of the 2-5A 131 
system has been shown to promote apoptosis in host cells (Castelli et al. 1997), we were interested 132 
in determining whether removal of the unproductive Oas1g splice site altered the levels of apoptotic 133 
cells.  We observed ~2-fold increase in the fraction of apoptotic cells in the engineered lines lacking 134 
the unproductive Oas1g splice site as compared to the control cells (Figure 2G) in unstimulated 135 
conditions.  We conclude that the increased Oas1g observed with the removal of the unproductive 136 
splice site leads to increased levels of apoptosis in a cell population.  137 
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Of note, the other enzymatically active member of the murine Oas1 family, Oas1a, has a 138 
highly homologous junction with an identical unproductive splice site.  However, despite nearly 139 
complete similarity of sequence at and nearby this splice-site (Figure S3A), it is used less frequently 140 
than that of Oas1g (Figure S3B-D).  Because of this similarity, our guide targeted to the unproductive 141 
splice site of Oas1g also cut at Oas1a (Figure S4), and genotyping confirmed all selected clones 142 
deleted the Oas1a unproductive splice site in addition to the Oas1g unproductive splice site.  Again, 143 
RT-PCR upon stimulation with poly(I:C) confirmed alternative splice site usage in control 144 
populations, and showed forced productive splicing in edited clones (Figure S3C).  To determine 145 
what effect this forced productive splicing has on Oas1a expression, we monitored Oas1a mRNA 146 
levels in both unstimulated and stimulated (8 hrs poly(I:C)) conditions.  In this case, we found that 147 
while the mean expression of Oas1a in both unstimulated and stimulated conditions was greater in 148 
non-engineered clones, the effect lacked significance (Figure S3D).  We hypothesize that the 149 
dampened effect with respect to Oas1a as compared to Oas1g is likely due to decreased usage of the 150 
unproductive splice site to begin with, but also note that the small differences observed in Oas1a 151 
expression levels could play a role in the aforementioned antiviral and apoptosis effects.   152 
 153 
Human Oas1 is Regulated at the Post-Transcriptional Level through Productive and 154 
Unproductive Alternative Splicing.  155 
Human Oas1 differs quite significantly from the mouse Oas1 paralogues, a finding that is perhaps 156 
not surprising given the volatile evolutionary history of the gene (Kumar et al. 2000; Hancks et al. 157 
2015; Fish and Boissinot 2016).  Despite differences between human Oas1 and mouse Oas1g, human 158 
Oas1 is extensively regulated at the post-transcriptional level through both productive and 159 
unproductive AS.  Productive AS at the 3' end of human Oas1 gives rise to six isoforms (p42, 160 
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p44(a/b), p46, p48, and p52) (Figure 3A) (Kjær et al. 2014).  Expression of these isoforms varies in 161 
humans.  For example, RNA-sequencing of IFN-α stimulated peripheral blood mononuclear cells 162 
(PBMCs) from two different healthy donors reveals one donor expresses primarily the p44a isoform, 163 
while the other expresses primarily the p46 isoform (Figure 3B).  Genetic variation at the p46 splice-164 
acceptor locus plays a role in this alteration of isoform abundance.  There exists a single G/A SNP 165 
(rs10774671) in the p46 exon 6 splice-acceptor.  Those with the G allele predominantly produce 166 
p46, while the A allele leads to production of the other isoforms (Figure 3A).  Of the isoforms, the 167 
p46 isoform has been shown to have the greatest oligoadenylate synthetase activity, an effect 168 
mediated at least in part by defects in protein accumulation of the other isoforms (Liu et al. 2017, 1; 169 
Bonnevie-Nielsen et al. 2005; Carey et al. 2019).  As might be expected, production of the high 170 
activity isoform has been shown to dampen susceptibility to and/or severity of a variety of viral 171 
infections, including those mediated by West Nile virus (Lim et al. 2009), Epstein-Barr virus (Liu et 172 
al. 2017) and hepatitis C virus (Knapp et al. 2003).  However, there also appear to be costs associated 173 
with high OAS1 activity in humans, most notably in response to dengue virus-2 infection (Simon-174 
Loriere et al. 2015).  The G allele, which leads to production of the high activity p46 Oas1 isoform, 175 
is associated with increased susceptibility to plasma leakage and shock in infected individuals, 176 
indicating immune overreaction could be triggered by increased OAS1 activity arising from altered 177 
AS (Simon-Loriere et al. 2015). 178 
In addition to the productive splicing events at the 3’ end of the Oas1 transcript that lead to 179 
the generation of multiple isoforms, we identified another unproductive splicing event at the third 180 
splice junction.  This unproductive splicing event is mediated by a 3’ splice site located 47 base pairs 181 
into exon 3.  When this unproductive splice site is selected, the frame of the transcript is shifted and 182 
a PTC is incorporated into the transcript, making it an ideal NMD substrate.  This unproductive 183 
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splice site is used frequently in a variety of cell types in response to a number of stimulation 184 
conditions (Figure 3C-E).  In general, ~10% of spliced reads at this junction splice to the 185 
unproductive 3’ splice site, though it is worth noting this potentially is an underestimation of the 186 
frequency of usage due to efficient degradation of PTC containing transcripts by the NMD decay 187 
machinery in the cytoplasm.  Thus, though human Oas1 and mouse Oas1g differ significantly, they 188 
are both regulated post-transcriptionally via AS.  189 
 190 
AS-NMD Events Are Common in Transcripts Related to Innate Immunity 191 
While Oas1g contained one of the most frequently used AS-NMD events, it was not the only AS-192 
NMD event found in genes related to the innate immune response.  For example, in nuclear 193 
fractionation RNA-sequencing data from mouse BMDMs stimulated with poly(I:C), we found 194 
significantly utilized cassette exon events that leads to a frameshift and incorporation of a PTC in 195 
the important innate immune response transcripts Mx1, IKKε, and Oasl2  (Figure 4A-C).  In each 196 
case, the event is utilized in all, or nearly all of the time-points post stimulation.  These events were 197 
also confirmed in the RAW264.7 macrophage cell line with RT-PCR upon stimulation with 198 
poly(I:C) for 4, 8, and 12 hours (Figure 4D-F).   199 
To classify AS-NMD events globally, we utilized the tool SplAdder to predict and quantify 200 
AS events supported by an input sample (Kahles et al. 2016).  A stringent confidence criterion was 201 
required to avoid including AS events derived from splicing noise.  Then, only events that lead to 202 
frameshifts and/or PTC inclusion were selected.  Among the list of AS-NMD events, as compared 203 
to a background of expressed genes, we observed significant enrichment for Gene Ontology (GO) 204 
terms associated with the innate immune response (Figure 4G).  With respect to the viral pathogen 205 
response, which is tasked with limiting viral replication through degradation of viral (as well as non-206 
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viral) mRNA and establishment of a cellular antiviral state, a host of factors involved with the 207 
response contain AS-NMD events identified here or in other published work (Frankiw et al. 2019) 208 
(Figure 4H). 209 
 210 
Discussion 211 
The robust and coordinated gene expression program involved in the defense against pathogens 212 
requires tight regulation.  In this study, we sought to shed light on the role of AS-NMD in this 213 
regulation.  We identified a frequently used unproductive splicing event in Oas1g, an important 214 
murine anti-viral response factor, and show that forced productive splicing leads to increased Oas1g 215 
expression and further, an increased ability to clear virus.  Additionally, we identified a number of 216 
other examples of unproductive splicing events in the innate immune response which could subject 217 
the corresponding transcript to decay via the NMD pathway.   218 
With respect to Oas1g, what benefit might this AS event offer?  The alternative splice site 219 
mediating this AS-NMD event is of comparable strength to the consensus 5’ splice site (Figure S1C).  220 
If possession of the greatest pathogen defense were the only goal of an organism, it seems unlikely 221 
this splice site would be retained.  However, while pathogen defense systems can provide a protective 222 
benefit, they also can cause collateral damage to a host.  With respect to Oas1, its pathogen defense 223 
effects are repeatedly forfeited by a host due to the fact that its activity can be so detrimental (Carey 224 
et al. 2019; Kjaer et al. 2009).  This is exemplified by the surprisingly high frequency of loss-of-225 
function mutations in Oas1 in primates (Carey et al. 2019), and the fact that OAS1 activity has been 226 
completely lost in several animal lineages, including teleost fish and insects (Kjaer et al. 2009).  227 
Moreover, while mice deficient for RNase L, the downstream effector of Oas1 in the 2-5A system, 228 
exhibit susceptibility to viral infection (Zhou et al. 1997), in the absence of infection they display 229 
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significantly increased longevity (Andersen et al. 2007).  Given the fact that host RNAs have been 230 
shown to be able to activate OAS enzymes, it is reasonable to hypothesize that the longevity effect 231 
is mediated, at least in part, by chronic 2-5A production (Carey et al. 2019; Molinaro et al. 2006; 232 
Dan et al. 2012; Li et al. 2017).  With respect to the AS-NMD event we observed in Oas1g, we found 233 
removal of the unproductive splice site significantly increased the number of cells undergoing 234 
apoptosis.  From this, it stands to reason that removal of the unproductive splice site, while improving 235 
the ability to limit viral infection, could negatively impact host fitness.  In turn, we believe this splice 236 
site represents a compromise between the pathogen protective benefits and collateral damage 237 
associated with OAS1g activity. 238 
A second question has to do with the manner with which this mitigation occurs.    Innately, 239 
regulation at the post-transcriptional level through AS-NMD appears inefficient.  Why spend the 240 
resources to transcribe a transcript if it is destined only for degradation?    For one, the very fact that 241 
introns exist and are transient in nature argues against the idea that the cost of transcription is 242 
prohibitive (Lareau et al. 2007a).  A significant majority of transcribed sequence (~90% in humans) 243 
is spliced and discarded.  Additionally, it is well understood that transcriptional regulation is largely 244 
a cooperative venture (Spitz and Furlong 2012), epitomized by complexes like the IFN-β 245 
enhanceosome (Thanos and Maniatis 1995).  As transcriptional regulation is not simply one protein 246 
interacting with one DNA sequence, but instead a multitude of proteins interacting with a host of 247 
other proteins and a variety of DNA sequences, it is possible that once transcriptional control has 248 
been placed on a system, changing it quantitatively is difficult as it requires the coordination of many 249 
different mutational events.  Thus, secondary mechanisms must be brought into play to fine-tune the 250 
gene expression levels of particular transcripts.  As such, we argue that the fine-tuning capabilities 251 
inherent to splicing-based post-transcriptional regulation far outweigh the cellular cost of additional 252 
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transcription, especially in the context of a tightly regulated gene expression program like 253 
inflammation. 254 
It remains unknown whether the AS-NMD event in Oas1g is regulated by an external input 255 
or whether a constant fraction of transcripts is discarded.  The fact that the alternative splice site for 256 
Oas1g and Oas1a are identical in sequence and further, both junctions are nearly identical, supports 257 
the idea that trans-acting proteins might affect the process.  Further, we notice a trend whereby 258 
increases in stimulation time accompany decreases in usage of the unproductive splice site (Fig. 1C), 259 
in essence arguing that this AS-NMD event acts as a break on Oas1g induction.  It is possible that 260 
this trend is controlled by trans-acting proteins which promote the selection of the productive splice 261 
site over the unproductive splice site, and are induced by poly(I:C) and/or viral stimulation.  Newly 262 
developed methods like RAP-MS (McHugh et al. 2015) and ChIRP-MS (Chu et al. 2015), which 263 
identify RNA binding proteins bound to RNAs of interest, could help discover interactions that have 264 
the ability to affect splice site selection. 265 
In summary, we found a frequently used AS-NMD event in Oas1g.  When the splice site that 266 
mediates this event is removed, we observed increased expression of Oas1g, an improved antiviral 267 
response, as well as an increase in the fraction of apoptotic cells.  We hypothesize this event exists 268 
as a compromise between the pathogen protective benefits and collateral damage associated with 269 
OAS1g activity.  Similar unproductive splicing events were found throughout the innate immune 270 
response.  While future studies should seek to understand the functional significance of individual 271 
events, this form of unproductive splicing has the potential to play a role in the regulation of gene 272 
expression in innate immunity. 273 
 274 
 275 
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Figure Legends 301 
Figure 1. Oas1g has a Frequent AS-NMD Event. (A) A schematic depiction an alternative splicing 302 
event leading to either a productive isoform destined for translation or an unproductive isoform 303 
destined for degradation.  (B) Sashimi plot for the entire gene body of Oas1g from BMDMs 304 
stimulated with poly(I:C) for 12 hrs.  Oas1g is a negative strand gene and is depicted right to left.  305 
(C) (left) Sashimi plots centered at the third junction of Oas1g from BMDMs stimulated with 306 
poly(I:C) for 0, 1, 4, 8, and 12 hrs. (right) Ψ estimates (red line), as well as confidence intervals over 307 
estimates (histogram) for each time point.  (D) Schematic representation of the alternative junction 308 
usage calculation.  (E)  Pie chart representing alternative junction usage for all expressed junctions 309 
upon 8 hrs. of poly(I:C) stimulation.  The slice including the alternatively spliced third junction of 310 
Oas1g is depicted by the arrow.   311 
 312 
Figure 2. Removal of Alternative Splice Site Alters Oas1g Expression and Macrophage 313 
Response to EMCV. (A) Schematic representation of the two alternative splice isoforms, and the 314 
gRNA/Cas9 targeting of the alternative splice site. (B) Sanger sequencing gDNA from a control 315 
sample (top) and an Oas1 SS KO sample (bottom).  Sequencing is oriented such that the negative 316 
strand runs left to right.  The alternative splice site is represented by the yellow highlighted region.  317 
(C) RT-PCR upon stimulation with poly(I:C) confirming alternative splice site usage in control 318 
populations and forced productive splicing in fixed clones.  (D)  RT-qPCR analysis of Oas1g mRNA 319 
levels in unstimulated and stimulated (8 hrs poly(I:C)) macrophages.  Control samples are 320 
represented in light blue, SS KO clones are represented in dark blue.  (E)  RT-qPCR analysis of 321 
Oas1g mRNA levels in EMCV infected (18 hrs) macrophages.  Control samples are represented in 322 
light blue, SS KO clones are represented in dark blue.  (F)  RT-qPCR measurement of EMCV viral 323 
load following 18 hrs of infection at 1 MOI.  Control samples are represented in light blue, SS KO 324 
clones are represented in dark blue.  (G)  Annexin V staining for apoptotic cells under unstimulated 325 
conditions.  Control samples are represented in light blue, SS KO clones are represented in dark blue.  326 
Data is representative of two independent experiments (D-G) and is shown as mean (error bars 327 
indicate SEM). * denotes p < 0.05, ** denotes p < 0.01, and *** denotes p < 0.001 using a Student’s 328 
t test.  Results are presented relative to those of Rpl32 (D-F). 329 
 330 
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Figure 3. Human Oas1 is Regulated at the Post-Transcriptional Level through Productive and 331 
Unproductive AS.  (A) Depiction of the mRNA splice isoforms found in human Oas1.  There exists 332 
a single G/A SNP in the OAS1 exon 6 splice-acceptor (rs10774671), with the G variant producing 333 
the more active p46 isoform.  (B) Sashimi plots depicting the productive AS event at the 3’ end of 334 
human Oas1.  RNA is from PBMCs stimulated with IFN-α derived from two healthy donors.  (C-335 
E) Sashimi plots for an AS-NMD event identified in exon 3 of human Oas1 from healthy donor 336 
derived PBMCs either unstimulated (top) or stimulated with IFN-α (C), A549 cells uninfected (top) 337 
or infected with Influenza Virus PR8 (D), or primary macrophages from two separate donors 338 
infected with West Nile virus (E). 339 
 340 
Figure 4. AS-NMD Events Are Common in Transcripts Related to Innate Immunity.  (A) 341 
Sashimi plots for an AS-NMD event identified in Mx1 from BMDMs stimulated with poly(I:C) for 342 
0, 1, 4, 8, and 12 hrs.  (B) Same as (A) for IKKε.  (C) Same as (A) for Oasl2.  (D) RT-PCR of Mx1 343 
upon stimulation with poly(I:C) for 4, 8, and 12 hrs.  (E) Same as (D) for IKKε.  (F) Same as (D) for 344 
Oasl2 (G) GO terms enriched for AS-NMD events, as compared to a background of expressed genes.  345 
(H) Schematic representation of major pathways in the viral pathogen response.  Red arrows are 346 
shown above factors containing AS-NMD events.  Data is representative of two independent 347 
experiments (D-F). 348 
 349 
 350 
 351 
 352 
 353 
 354 
 355 
 356 
 357 
 358 
 359 
 360 
 361 
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Methods 362 
 363 
Contact for Reagent and Resource Sharing 364 
Further information and requests for resources and reagents should be directed to and will be fulfilled 365 
by the Lead Contact, David Baltimore (baltimo@caltech.edu). 366 
 367 
Experimental Model and Subject Detail 368 
Cell Culture 369 
All cell lines were maintained at 37°C.  Human embryonic kindey cells (HEK293T) from ATCC 370 
were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep.  RAW 264.7 murine 371 
macrophages from ATCC were cultured in DMEM supplemented with 10% FBS and 1% Pen/Strep.  372 
Cell lines were maintained at 37°C in 5% CO2. 373 
 374 
Method Detail 375 
RNA Isolation 376 
Total RNA was purified from BMDMs using TRIzol reagent (Ambion) as per the manufacturer’s 377 
instructions.  Genomic DNA in RNA purifications was eliminated through treatment with Turbo 378 
DNase (Thermo Fisher Scientific) for 30 min at 37°C.   379 
 380 
RT-PCR of Splice Isoforms 381 
Total RNA was isolated using Tri reagent solution and digested with DNase I (Invitrogen). RT 382 
reactions were performed in 20µL (20mM DTT, 2X ProtoScript II Reverse Transcriptase Reaction 383 
Buffer (NEB), 1mM dNTPs, 40U Murine RNAse Inhibitor (NEB), and 200U ProtoScript II (NEB) 384 
Reverse Transcriptase) with 500-1000ng RNA. Reaction incubated in thermocycler with the 385 
following program: 1. 42°C for 60min, 2. 65°C for 20min.  PCR was performed using Q5 Hot Start 386 
High-Fidelity DNA Polymerase (NEB) and gene specific primers.  387 
 388 
CRISPR Experiments 389 
RAW 264.7 cell lines were grown in individual 10cm plates.  20,000 cells were plated in a cell well 390 
plate and left overnight to adhere.  Following adherence, lentvirus expressing Cas9 and either the 391 
Oas1a/g guide or a scramble control guide was added to the cells.  48 hours later, infected cells were 392 
selected with puromycin, which was added at a concentration of 3.75ug/mL.  Following 72 hours of 393 
selection, cells infected with the Oas1a/g guide were single-cell plated in 96 well plates.  Clones 394 
were passed to 6-well plates following 5 days of growth, at which point genotyping was performed.  395 
Cells infected with the scramble control guide were passaged as a bulk infected population, with 396 
independent biological replicates representing cells independently infected and puromycin selected. 397 
  398 
Poly(I:C) Stimulations 399 
RAW 264.7 cell lines were grown in individual 10cm plates.  12 hours prior to infection cells were 400 
counted and plated at a density of 350,000 cells/well in 6 well plate.  Following adherence, 5ug/mL 401 
of Poly(I:C) (Sigma) was added.  Following the infection, cells were lysed in TRIzol.  Viral RNA 402 
was quantified as described above.  Cellular RNA was quantified using TaqMan PCR probes (see 403 
Supplemental Table 1 for probes; Thermo Fisher). 404 
  405 
 406 
 407 
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EMCV Infection Experiment 408 
RAW 264.7 cell lines were grown in individual 10cm plates.  12 hours prior to infection, cells were 409 
counted and plated at a density of 350,000 cells/well in 6 well plate.  Following adherence, EMCV 410 
was added at the specified MOI for the specified amount of time.  Following the infection, cells were 411 
lysed in TRIzol.  Cellular and viral RNA was quantified using SYBR green (Kapa Biosystems).  All 412 
oligonucleotide sequences can be found in Supplemental Table 1. 413 
 414 
Annexin V Experiment 415 
RAW 264.7 cell lines were grown in individual 10cm plates.  12 hours prior to infection, cells were 416 
counted and plated at a density of 125,000 cells/well in 12 well plate.  24 hours after plating, cells 417 
were stained with Annexin V APC Ready Flow Conjugate (Thermo Fisher).  Samples were analyzed 418 
on a MACSQuant10 Flow Cytometry machine (Miltenyi).  Data was analyzed with FlowJo 10.2. 419 
 420 
Data Download 421 
Raw RNA-sequencing samples in FASTQ format were downloaded from the Gene Expression 422 
Omnibus (GEO) database.  Mouse bone-marrow macrophages derived data data can be found under 423 
accession number GSE122543 (SRR8187909, SRR8187910, SRR8187911, SRR8187912, 424 
SRR8187913).  Human PBMC data can be found under accession number GSE72502 425 
(SRR2192716, SRR2192719, SRR2192720).  Human A549 data can be found under accession 426 
number GSE121155 (SRR8037285, SRR8037289).  Human primary macrophage data can be 427 
found under accession number GSE40718 (SRR566252, SRR566260).  428 
 429 
RNA-Sequencing Analysis 430 
Sequencing was performed on a HiSeq 2500 High Throughput Sequencer (Illumina).  All previously 431 
downloaded RNA-seq samples were aligned using a pipeline based on the STAR aligner (version 432 
2.6.0a)(Dobin et al. 2013).  The STAR software (version 2.6.0a) was used in a 2-pass mode.  The 433 
first pass identifies non-annotated junctions in the input, allowing for the construction of a genome 434 
index containing non-annotated junctions. The second pass alignment is then performed against the 435 
junction-aware index.  Following alignment, Portcullis(Mapleson et al. 2018) was used to filter 436 
invalid splice junctions from the aligned BAM file.  Isoform expression was quantified using 437 
the raw fastq files and the mouse reference transcriptome mm9 as input for Kallisto 438 
(v.0.45.0)(Bray et al. 2016).  The resultant normalized transcript frequencies were provided to 439 
the R package Sleuth for differential analysis (v.0.30.0)(Pimentel et al. 2017).  Alternative 440 
splicing events were detected and quantified on produced BAM files using 441 
the SplAdder toolkit(Kahles et al. 2016) as per Kahles et al., 2018(Kahles et al. 2018).  Only events 442 
that passed the highgest confidence level parameter were selected.  Unproductive splicing events 443 
were determined using a custom Python script.  Alternative splicing sashimi plots across an entire 444 
gene were generated with ggsashimi(Garrido-Martín et al. 2018) whereby only junctions with greater 445 
than 5 supporting RNA-seq reads were plotted, while alternative splicing sashimi plots centered at 446 
an individual junction were generated with MISO(Katz et al. 2010).  Ψ estimates, as well as 447 
confidence intervals over estimates shown in histograms of Figure 1C were generated using only 448 
reads from the most abundant read length. 449 
 450 
Alternative Junction Usage Analysis 451 
Isoform expression was quantified using the raw fastq files and the mouse reference 452 
transcriptome mm9 as input for Kallisto (v.0.45.0).  Only isoforms with a TPM greater than 10 453 
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were considered.  Junctions from the most abundant isoform for each gene were selected, as 454 
long as there were 8 supporting reads for the junction.  Alternative junction usage was 455 
calculated by comparing the number of reads that overlap a given selected junction, but did not 456 
utilize the same 5’ and/or 3’ splice site, to the total number of reads at a junction.   457 
 458 
Quantification and Statistical Analysis 459 
All statistical analysis was performed in Python (version 2.7.9).  Unless otherwise indicated in figure 460 
legends, statistical significance measurements were marked as follows: * denotes p < 0.05, ** 461 
denotes p < 0.01, *** denotes p < 0.001, and n.s. denotes not significant.   462 
 463 
 464 
 465 
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Supplemental Figure Legends 627 
Figure S1. The Alternative 5’ Splice Site Mediating the AS Event is of Similar Strength to the 628 
Consensus 5’ Splice Site. (A) RT-qPCR analysis of Upf1 mRNA levels in unstimulated 629 
macrophages expressing a scrambled shRNA (light blue) or one of two Upf1 targeted shRNAs 630 
(darker blue).  (B) RT-qPCR analysis of Oas1g mRNA levels in poly(I:C) stimulated (8 hrs.) 631 
macrophages expressing a scrambled shRNA (light blue) or one of two Upf1 targeted shRNAs 632 
(darker blue).  (C) Histogram representing the 5’ splice site strength (MaxEntScore) of introns of 633 
expressed in BMDMs.  The bin with which the consensus splice site falls is shown by the light blue 634 
line.  The bin with which the alternative splice site falls is shown by the dark blue line.  (D) Pie chart 635 
representing alternative junction usage for all expressed junctions upon 4 hrs. of poly(I:C) 636 
stimulation.  The slice including the alternatively spliced third junction of Oas1g is depicted by the 637 
arrow.  (E) Same as (D) but for 8 hrs. of poly(I:C) stimulation.  Data is representative of two 638 
independent experiments (A, B) from three biological replicates (error bars indicate SEM). * denotes 639 
p < 0.05, ** denotes p < 0.01, and *** denotes p < 0.001 using a Student’s t test.  Results are 640 
presented relative to those of Rpl32 641 
  642 
Figure S2. Oas1g Macrophage Cell Line Genotyping.  Sanger sequencing gDNA from a control 643 
sample (very top) and the Oas1g SS KO clones.  Sequencing is centered around the Oas1g alternative 644 
splice site.  Sequencing is oriented such that the negative strand runs left to right. 645 
 646 
Figure 3. Oas1a has a Similar Frequently Utilized AS-NMD Event.  (A) Schematic depiction 647 
showing the homology between Oas1a and Oas1g at the alternatively spliced third junction.  (B) 648 
(left) Sashimi plots centered at the third junction of Oas1g from BMDMs stimulated with poly(I:C) 649 
for 0, 1, 4, 8, and 12 hrs. (right) Ψ estimates (red line), as well as confidence intervals over estimates 650 
(histogram) for each time point. (C) RT-PCR upon stimulation with poly(I:C) confirming alternative 651 
splice site usage in control populations and forced productive splicing in fixed clones.  (D)  RT-652 
qPCR analysis of Oas1g mRNA levels in unstimulated and stimulated (8 hrs poly(I:C)) 653 
macrophages.  Control samples are represented in light blue, SS KO clones are represented in dark 654 
blue.  Data is representative of two independent experiments (D-F) and is shown as mean (error bars 655 
indicate SEM). * denotes p < 0.05, ** denotes p < 0.01, and *** denotes p < 0.001 using a Student’s 656 
t test.  Results are presented relative to those of Rpl32 (D) 657 
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Figure S4. Oas1a Macrophage Cell Line Genotyping.  Sanger sequencing gDNA from a control 658 
sample (very top) and the Oas1a SS KO clones.  Sequencing is centered around the Oas1a alternative 659 
splice site.  Sequencing is oriented such that the negative strand runs left to right.   660 
 661 
Supplemental Table 1: Oligonucleotides   662 
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